当前位置: 首页 >> 检索结果
共有 5414 条符合本次的查询结果, 用时 6.1574268 秒

101. IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis.

作者: Zhongshan He.;Yaoyao Luo.;Zhonghui Duan.;Bin Su.;Wanqin Zeng.;Yu Guo.;Yongjiang Li.;Xi He.;Haixing Shi.;Zhuoming Zhou.;Chunling Jiang.;Duotian Qin.;Ji Zhang.;Yan Kang.;Wei Chen.;Xiangrong Song.
来源: Circulation. 2025年
Impaired efferocytosis of macrophages within advanced atherosclerotic plaques leads to plaque deposition and rupture, ultimately resulting in atherothrombotic events. Effective restoration of efferocytic capacity in lesional macrophages remains a challenge in atherosclerosis treatment.

102. Clopidogrel Versus Aspirin Beyond 30 Days: Different Drugs, Same Outcomes?

作者: Irene Santos-Pardo.;Mamas Andreas Mamas.
来源: Circ Cardiovasc Interv. 2025年18卷11期e016057页

103. Semaglutide After Catheter Ablation: A New Chapter in Atrial Fibrillation Care?

作者: Melissa E Middeldorp.;Elnaz Shahmohamadi.
来源: Circ Arrhythm Electrophysiol. 2025年18卷11期e014508页

104. CKAP4 Promotes Atrial Fibrosis and Enhances Atrial Fibrillation Vulnerability via WNT/β-Catenin Activation.

作者: Yuntao Feng.;Zhisong Chen.;Yanhua Gao.;Xuebo Liu.;Hongwei Tan.
来源: Circ Arrhythm Electrophysiol. 2025年18卷11期e014217页
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, characterized by atrial fibrosis, a crucial substrate facilitating its initiation and persistence. CKAP4 (cytoskeleton-associated protein 4) has been associated with fibroblast activation; however, its involvement in atrial remodeling and AF susceptibility remains unclear.

105. MEPPC Syndrome: A Systematic Review and State-of-the-Art Paper.

作者: Paolo Basile.;Maria Cristina Carella.;Stefania Zaccaro.;Marco Maria Dicorato.;Luca Sgarra.;Yamna Khan.;Gianluca Pontone.;Giovanni Luzzi.;Vincenzo Ezio Santobuono.;Cinzia Forleo.;Marco Matteo Ciccone.;Andrea Igoren Guaricci.
来源: Circ Arrhythm Electrophysiol. 2025年18卷11期e014113页
Multifocal ectopic Purkinje-related premature contractions syndrome presents as a rare cardiac disorder characterized by frequent multifocal ectopic ventricular beats with narrow QRS complexes, originating from various ectopic foci along the fascicular-Purkinje system. It is characterized by mutations in the SCN5A gene, inducing a gain-of-function in the human cardiac voltage-gated Na+ channel (Nav1.5), which causes an alteration in the action potentials of the cardiomyocytes. The syndrome was initially delineated in 2012 by Laurent et al in 3 Dutch families, subsequently garnering recognition through several reported cases worldwide. Clinically, it often manifests with a familial predisposition to other arrhythmogenic cardiac diseases, alongside symptoms such as palpitations and syncope. A key diagnostic hallmark is the high daily burden of multifocal premature ventricular contractions observed on 24-hour dynamic ECG, with evidence of repetitive ventricular arrhythmias. This can potentially induce a reversible form of left ventricular dilation with systolic dysfunction, known as premature ventricular contraction-induced cardiomyopathy. Diagnosis may be challenging, requiring exclusion of the most frequent causes of ventricular arrhythmias first. The disappearance of arrhythmias during a stress test and the inefficacy of catheter ablation procedures may serve as additional elements to bolster the suspicion of multifocal ectopic Purkinje-related premature contractions syndrome. Genetic testing and electrophysiological studies are pivotal in confirming the diagnosis. Therapeutic management of this syndrome primarily involves medical therapy with class I antiarrhythmic drugs, such as flecainide and quinidine, which may reduce ventricular arrhythmias and associated symptoms. In this systematic review, our aim was to provide an exhaustive insight into the genetic basis, diagnosis, and treatment strategies for this intriguing yet relatively underexplored syndrome.

106. Entropy in Hypertrophic Cardiomyopathy: A New Layer in Risk Stratification for Sudden Cardiac Death.

作者: Christopher Lee.;Theodore P Abraham.
来源: Circ Cardiovasc Imaging. 2025年18卷11期e019080页

107. Seeing the Unseen: Contrast-Free MRI for Predicting Thrombolytic Susceptibility.

作者: Liya Dai.;Jie Zheng.
来源: Circ Cardiovasc Imaging. 2025年18卷11期e019141页

108. Incidence and Predictors of Acute Urinary Retention After Atrial Fibrillation Pulsed Field Ablation: A Word of Caution on Routine Atropine Administration.

作者: Marco Bergonti.;Daniele Faccenda.;Francesco Cardinali.;Tardu Özkartal.;Paolo Compagnucci.;Maria Luce Caputo.;Antonio Dello Russo.;Esther Scheirlynck.;Michela Casella.;Giulio Conte.
来源: Circ Arrhythm Electrophysiol. 2025年18卷11期e014314页

109. Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.

作者: Lingyu Xu.;Stanislau Hrybouski.;Ting-Wei Ernie Liao.;Jessie Dong.;Mirmilad Khoshknab.;David Callans.;Francis E Marchlinski.;Walter R Witschey.;Benoit Desjardins.;Saman Nazarian.
来源: Circulation. 2025年
A 3-dimensional hyperboloid model has been proposed to characterize ventricular tachycardia (VT) circuitry. We sought to characterize the geometric features of viable corridors, derived from late gadolinium enhanced cardiovascular magnetic resonance, that participate in VT circuitry in ischemic cardiomyopathy.

110. Impact of Balloon Postdilation on Long-Term Bioprosthesis Durability After TAVR.

作者: Antonin Trimaille.;Pedro Cepas-Guillen.;Juan Hernando Del Portillo.;Carlos Giuliani.;Jean-Michel Paradis.;Eric Dumont.;Anthony Poulin.;Dimitri Kalavrouziotis.;Frederic Beaupré.;Jean Porterie.;Siamak Mohammadi.;Josep Rodés-Cabau.
来源: Circ Cardiovasc Interv. 2025年e015577页
While balloon postdilation (BPD) during transcatheter aortic valve replacement may enhance hemodynamic performance by optimizing valve expansion, it was also linked with leaflet mechanical stress, potentially reducing valve durability. The aim of this study was to investigate the impact of BPD on long-term bioprosthetic valve durability.

111. Relation of Residual Mitral Regurgitation and Gradient Following Mitral Valve Transcatheter Edge-to-Edge Repair.

作者: Donika Mustafa.;Jennifer von Stein.;Lukas Stolz.;Jean Marc Haurand.;Matthias Gröger.;Felix Rudolph.;Jannik Jobst.;Christoph Alexander Mues.;Amir Abbas Mahabadi.;Isabel A Hoerbrand.;Carl Schulz.;Atsushi Sugiura.;Philipp Lurz.;Tobias Kister.;Paula Sagmeister.;Charlotte Wolff.;Muhammed Gerçek.;Patrick Horn.;Mirjam Kessler.;Guido Ascione.;Tienush Rassaf.;Marcel Weber.;Niklas Schofer.;Mathias H Konstandin.;Florian Schindhelm.;Helge Möllmann.;Bernhard Unsöld.;Henning Guthoff.;Stephan Baldus.;Wolfgang Rottbauer.;Volker Rudolph.;Juan F Granada.;Jörg Hausleiter.;Roman Pfister.;Victor Mauri.;Philipp von Stein.; .
来源: Circ Cardiovasc Interv. 2025年18卷11期e015845页
Residual mitral regurgitation (rMR) ≤1+ has been associated with improved 1-year outcomes after mitral valve transcatheter edge-to-edge repair, regardless of the mean mitral pressure gradient (MPG). Prior evidence is limited to 30-day echocardiographic follow-up and patients treated with the MitraClip (Abbott Structural Heart). Whether rMR and MPG assessed at discharge are associated with outcomes after PASCAL mitral valve transcatheter edge-to-edge repair (Edwards Lifesciences) remains unknown.

112. Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association.

作者: Kristen L Knutson.;Debra D Dixon.;Michael A Grandner.;Chandra L Jackson.;Christopher E Kline.;Lisa Maher.;Nour Makarem.;Tami A Martino.;Marie-Pierre St-Onge.;Dayna A Johnson.; .
来源: Circulation. 2025年
Cardiovascular and metabolic health are influenced by the circadian system, which regulates 24-hour rhythms across numerous physiologic processes. Disruptions to circadian rhythmicity can adversely affect cardiometabolic function and health. Given the importance of circadian health to overall human health, this scientific statement provides an overview of the circadian system and key behavioral factors that can synchronize or desynchronize these rhythms, including light exposure, food intake, physical exercise, and sleep timing. We also summarize the literature on associations between circadian health and cardiometabolic health indicators, such as excessive weight, type 2 diabetes (T2D), hypertension, and cardiovascular disease. We discuss strategies to improve circadian health and reduce circadian disruptions, focusing on interventions that target the key synchronizers of circadian rhythms and involve appropriate timing of exposure to these synchronizers. These include morning bright light exposure and avoidance of light at night, as well as appropriately timed sleep, meals, and exercise. Clinicians, researchers, policymakers, and the public should recognize the role of circadian rhythms in maintaining and promoting cardiometabolic health and focus on identifying modifiable behaviors that can improve them.

113. Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials.

作者: Yuko Kiyohara.;Tadao Aikawa.;Tetsuya Saito.;Abel Casso Dominguez.;Jose Wiley.;Dhaval Kolte.;Eric A Secemsky.;Robert W Yeh.;Roger J Laham.;Azeem Latib.;Deepak L Bhatt.;Toshiki Kuno.
来源: Circ Cardiovasc Interv. 2025年e016005页
It remains unclear whether drug-coated balloons (DCBs) and drug-eluting stents are comparable in the treatment of coronary artery disease (CAD) and whether limus versus paclitaxel DCBs yield similar clinical outcomes. We aimed to assess the clinical efficacy of limus and paclitaxel DCBs in patients with CAD through a network meta-analysis.

114. The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.

作者: Christopher A Rajkumar.;Michael J Foley.;Fiyyaz Ahmed-Jushuf.;Shayna Chotai.;Florentina A Simader.;Muhammad Mohsin.;Ahmed Salih.;Sashiananthan Ganesananthan.;Nina Bual.;Ricardo Petraco.;Sukhjinder S Nijjer.;Sayan Sen.;Joban Sehmi.;Neil Ruparelia.;Jason N Dungu.;Alamgir Kabir.;Kare Tang.;Reto Gamma.;John R Davies.;Tushar Kotecha.;Graham D Cole.;James P Howard.;Thomas R Keeble.;Gerald J Clesham.;Peter D O'Kane.;Frank E Harrell.;Darrel P Francis.;Matthew J Shun-Shin.;Rasha K Al-Lamee.
来源: Circulation. 2025年
Little correlation exists between the burden of ischemia and severity of angina in patients with stable coronary artery disease. This placebo-controlled, n-of-1 study investigated the relationship between ischemia, the collateral circulation, and symptoms in stable coronary artery disease. Additionally, it explored the association between progressive collateral recruitment and ischemic preconditioning.

115. Expert Hands, Favorable Curves: Parsing the Evidence for Early Mitral Valve Repair.

作者: David H Adams.;Dimosthenis Pandis.
来源: Circulation. 2025年152卷17期1218-1220页

116. Remote Ischemic Preconditioning in Noncardiac Surgery: Time to Reconsider or Refocus?

作者: Hans Erik Bøtker.
来源: Circulation. 2025年152卷17期1206-1208页

117. Collateral Damage From Congenital Heart Surgery: Can Thymic Reimplantation Restore Immune Competence?

作者: Carolina Moore.;Tara Karamlou.;David L S Morales.
来源: Circulation. 2025年152卷17期1191-1193页

118. Introduction to the 2025 Cardiovascular Surgery-Themed Issue of Circulation.

作者: Marc Ruel.
来源: Circulation. 2025年152卷17期1187页

119. Surgery for Periprocedural Failure of Transcatheter Aortic Valve Replacement in the United States.

作者: Thomas A Schwann.;Robert H Habib.;Siavash Saadat.;Amr E Abbas.;Mario F L Gaudino.;Daniel T Engelman.;Aaron Kugelmass.;Milo Engoren.
来源: Circulation. 2025年152卷17期1262-1264页

120. Current Status of Donation After Circulatory Determination of Death Heart Transplantation.

作者: John Onsy Louca.;Steven Tsui.;Stephen Large.
来源: Circulation. 2025年152卷17期1188-1190页
共有 5414 条符合本次的查询结果, 用时 6.1574268 秒